Hyderabad-based biotechnology company BioVaram, the brand name of the UR Advanced Therapeutics Pvt Ltd. (URAT) and Japan’s company Teijin Limited announced today that they have signed a business alliance agreement to explore opportunities for expanding usage of Teijin Group’s implantable medical devices and regenerative medicine products in India, as well as introducing BioVaram’s product portfolio into the Japanese market.

The two companies share a vision to address unmet medical needs in Japan—one of the world’s most advanced healthcare markets—and India, where healthcare innovation is accelerating. This alliance aims to leverage each company’s strengths to deliver cutting-edge solutions across both nations.

Advertisement

Under the agreement, Teijin and BioVaram will explore:

– Regul

See Full Page